SEC Form 4 · accession 0001213900-19-001108
Intec Pharma Ltd. · NTEC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walt Addison Linscott
Officer — Chief Business Officer
Period of report
Jan 22, 2019
Accepted (ET)
Jan 23, 2019 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001638381
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.628 | Jan 22, 2019 | A | 90,000 | A | — | Jan 22, 2026 | Ordinary Shares | 90,000 | 90,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through January 22, 2022.